To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
April is Parkinson’s Awareness Month, so what better time to refresh your understanding and promote awareness around Parkinson disease than now?
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
This expansion of their role goes beyond traditional dispensing duties, positioning pharmacists as an essential bridge between patients and the broader health care system.
These disorders can be fatal, making pharmacists’ role in detection crucial.
In this high-risk population, strategies for minimizing viral exposure during a pandemic are being considered with oncology treatment options.
The drug may be a risk factor for dementia-related illnesses.
The money could be used for prevention and treatment services, health care practitioner training, or other ways to stem the epidemic.
Between December 22, 2024, and March 7, 2025, reported measles cases in the US climbed precipitously.
Billions of samples are discarded while investigators struggle to assemble collections.
Emma Murter, PharmD, MPH, and Madison N. Irwin, PharmD, BCPS, discuss the potential role of low-dose naltrexone in managing chronic pain in palliative care, highlighting its anti-inflammatory properties, limited adverse effects, and current evidence gaps—particularly in comparison to traditional opioids and adjuvant analgesics.
HER2-low disease demands a different approach from that of HER2-negative disease.
AI is offering new ways to support pharmacists' decision-making and patient care.
Pharmacists can play a key role in providing education and guidance to patients with glaucoma.
The NJSHP's 2nd Annual Symposium fosters networking and education for pharmacy professionals, featuring expert insights on compliance and regulation in pharmacy compounding.
Pharmacists’ role in community-based cancer centers are expanding, with a more significant role in treatment plan selection, education, collaboration to create individualized care plans, managing adverse effects, and aiding with financial toxicities.
High adherence to treatment is a key first step toward better patient outcomes, including sustained disease control or remission.
Not only are pharmacists easily accessible to the public, they are also highly visible as a source for travel immunization services.
Patient education, naloxone training, and monitoring programs make a difference.
However, the cost of zuranolone makes it challenging to access and justify, given study results comparing it with brexanolone.
The future of vancomycin dosing lies in optimizing dosing regimens to individual patient needs.
Collaboration between AI-based platforms and health care organizations offers promising results.
In this roundtable, 3 pharmacy faculty members reflect on how shifting federal priorities and the defunding of research initiatives have impacted their work, communities, and careers—while highlighting the power of resilience, solidarity, and reimagined academic impact in advancing public health equity.
This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.
Interventions to improve medication adherence may have a greater impact on individual patients and the population as a whole than any novel treatment or therapy.
Pharmacists are uniquely positioned to play a frontline role in advancing health equity. This will require, however, that we build the pipeline of future pharmacists and preserve vital community touchpoints.
Routinely celebrating their work contributions and dedication adds value to your organization.
This medication is associated with a number of adverse effects, such as gastrointestinal upset and peripheral neuropathies, that may be mitigated by less frequent dosing.